Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DR26FHBQ5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,429
Award facts
- Contract value 100% obligated
- $35,429.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $35,429 by the Defense Logistics Agency on November 12, 2025, for the supply of Nexplanon 68 mg implants. The delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award is scheduled for ultimate completion by December 4, 2025, with performance to be executed at the contractor's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's recently awarded single-award Indefinite Delivery Contract (IDC) designated SPE2DR under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $500 million ceiling value and extends through December 31, 2036. The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to establish multiple regional prime vendor contractors to supply a comprehensive range of pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. Through this overarching contract vehicle, the Defense Logistics Agency leverages DMS Pharmaceutical Group's established performance and product expertise to support recurring medical supply needs across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FHBQ5?
SPE2DR26FHBQ5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26FHBQ5 worth?
The government has obligated $35,429 on SPE2DR26FHBQ5.
Is contract SPE2DR26FHBQ5 an order under another contract?
Yes. SPE2DR26FHBQ5 is a delivery order under SPE2DR25D9202, an indefinite delivery contract.
Was contract SPE2DR26FHBQ5 competed?
The extent of competition for SPE2DR26FHBQ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award